companydata.dkBiomedica-Anpartsselskab: Financial statements 2022
CVR: 15234474
Biomedica-Anpartsselskab (CVR 15234474) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 640,481 and a net result of DKK 497,881 compared with DKK 402,016 the year before. That is an increase of 25% compared with the year before. Equity amounted to DKK 1,834,447. The solvency ratio was 84.3%.
- Gross Profit
- 640,481 kr.
- Profit/Loss
- 497,881 kr.
- Equity
- 1,834,447 kr.
- Total Assets
- 2,176,994 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 640 t. | 498 t. | 1.8 mio. | - |
| 2021 | - | 512 t. | 402 t. | 1.3 mio. | - |
| 2020 | 2 mio. | 1.1 mio. | 828 t. | 916 t. | - |
| 2019 | 2.7 mio. | 1.7 mio. | 1.4 mio. | 107 t. | - |
| 2018 | 600 t. | 38 t. | 38 t. | -1.3 mio. | - |
Keep an eye on Biomedica-Anpartsselskab
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Biomedica-Anpartsselskab has published its annual report for 2021. Gross profit came to DKK 512,204, and the net result was DKK 402,016.
About Biomedica-Anpartsselskab
Biomedica-Anpartsselskab is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 1991. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Lars Anders Baumbach. The company is owned by Lars Anders Baumbach. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -28,050 compared with DKK 307,277 the year before. Equity amounted to DKK 2,702,360.